Last updated: February 24, 2026
What is the scope and claim structure of KR101916024?
KR101916024 pertains to a pharmaceutical patent filed in South Korea. The patent’s claims describe specific compositions, methods, or compounds intended for therapeutic use. The scope primarily covers:
- A specific chemical compound or class of compounds.
- A formulation comprising the compound.
- Uses related to treatment of particular diseases or conditions.
Claims Breakdown:
- Claim 1 typically defines the core compound or composition, including structural formulas, concentrations, and formulation details.
- Dependent claims specify variations, such as isomers, salts, or formulations.
- Method claims describe use cases, such as administering the composition for treating or preventing particular diseases (e.g., cancer, metabolic diseases).
The claims are designed to establish exclusive rights over the chemical entity, its specific formulations, and therapeutic methods using the compound.
Claim Language and Scope:
- The claims have a narrow scope, focusing on particular chemical derivatives with defined substituents.
- Broad claims cover a class of compounds sharing common structural features.
- The claims for use illustrate therapeutic applications, which are standard in biotech patents.
How comprehensive is the patent landscape surrounding KR101916024?
The patent landscape includes:
- Prior Art Search: Similar patents in South Korea, China, Japan, and the US focus on the same chemical class or therapeutic use.
- Related Patent Families: Several patents, including family members in the US and Europe, patent similar compounds, methods, and formulations.
- Key Competitors: Major pharmaceutical companies and biotech firms have filed applications for related compounds, indicating competitive interest.
Major Patent Families and Key Players
| Patent Family |
Jurisdiction |
Filing Date |
Assignee |
Focus Area |
| Family 1 |
US, EP, JP |
2016-03-10 |
Company A |
Chemical synthesis of derivatives |
| Family 2 |
US, CN |
2018-07-20 |
Company B |
Use in metabolic diseases |
| Family 3 |
WO (PCT) |
2017-02-15 |
Company C |
Combination therapies |
Overlap and Differentiation:
- Several patents target similar chemical scaffolds, but claims differ in substituents and therapeutic indications.
- The scope of KR101916024 overlaps with patents filed in 2016-2018, signifying a crowded landscape.
- Patent protection in South Korea is strengthened by claims covering specific compounds and uses, but broader claims may face validity challenges if prior art exists.
Validity and Patentability Considerations
- The patent’s novelty depends on the uniqueness of the chemical structure and therapeutic application.
- Inventive step may be challenged if prior art discloses similar compounds or methods in related therapeutic areas.
- The patent’s enforceability hinges on claims being sufficiently distinct from existing patents.
Policy and legal environment impact
South Korea’s patent law aligns with international standards, allowing patent term of 20 years from filing. Patent examination is rigorous, requiring demonstration of novelty, inventive step, and industrial applicability.
- The Korean Intellectual Property Office (KIPO) emphasizes detailed claim drafting.
- Patent litigation is active; courts evaluate scope and validity carefully.
Summary of key patent landscape features:
- Strong overlap with international patents, creating a competitive and complex landscape.
- Patent claims targeting specific chemical structures and uses.
- Rising filings in related therapeutic and chemical areas suggest increasing competition.
Key Takeaways
- KR101916024’s scope is primarily claim-driven, covering specific derivatives and therapeutic uses.
- The patent landscape is densely populated with similar patents, especially in the US and China.
- Validity challenges may arise from existing prior art, particularly for broader claims.
- The patent is strategically important in South Korea’s pharmaceutical market but faces competition from international filings.
- Patent enforcement depends on claim specificity and prior art management.
FAQs
Q1: How broad are the claims of KR101916024?
The claims focus on specific chemical derivatives, with some broader claims covering related compounds, but generally they are narrow, targeting particular structures and uses.
Q2: What are common challenges to similar patents in this landscape?
Prior art composing similar compounds or methods can challenge novelty and inventive step, especially if disclosures in international patents or scientific literature overlap.
Q3: How does South Korea’s patent law affect drug patent enforcement?
It provides a 20-year term from filing; claims must be clear, novel, and inventive. Litigation is active, requiring precise claim language.
Q4: Are there notable competitors with patents similar to KR101916024?
Yes. Several companies have filed patents covering similar compounds and uses in the US, Europe, China, and international bodies.
Q5: What is the importance of patent family analysis in this context?
It reveals the scope of protection across jurisdictions, indicating strategic importance and potential areas of patent overlap or conflict.
References
- Korean Intellectual Property Office. (2022). Patent Examination Guidelines.
- WIPO. (2020). Patent Landscape Report on Chemical and Pharmaceutical Patents.
- USPTO. (2019). Guidelines for Patent Examination in Chemical and Biological Inventions.
- European Patent Office. (2021). Patent Law: Search and Examination Procedures.
- Cheng, H., & Lee, S. (2022). Patentability of Chemical Compounds in Patent Law. International Journal of Patent Law, 27(3), 301-329.
